Only Half of Kidney Stone Patients Compliant With Tx

This article originally appeared here.
Share this content:
Only Half of Kidney Stone Patients Compliant With Tx
Only Half of Kidney Stone Patients Compliant With Tx

FRIDAY, Feb. 19, 2016 (HealthDay News) -- Just over half of kidney stone patients are adherent to preventive pharmacological therapy, and adherent patients have lower levels of health care utilization, according to a study published in the March issue of The Journal of Urology.

Casey A. Dauw, M.D., from the University of Michigan in Ann Arbor, and colleagues assessed medication adherence among adult patients with a diagnosis of kidney stones. By accessing medical and pharmacy claims data, adherence to therapy within the first six months of initiating treatment was measured using the proportion of days covered formula. Adherence was defined as a proportion of days covered value of 80 percent or greater.

The researchers found that just over half (51.1 percent) of 8,950 eligible patients were adherent to preventive pharmacological therapy. Adherent patients had lower odds of emergency department visits (odds ratio [OR], 0.73), hospitalization (OR, 0.59), and surgery for stone disease (OR, 0.77), compared to nonadherent patients.

"To improve adherence further research is needed to understand patient and provider level factors that contribute to lower rates of adherence," the authors write.

One author disclosed financial ties to the medical device industry.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »